盐酸缬更昔洛韦片的价格多少呢？

It is an oral anti-cytomegalovirus infection drug developed by the Swiss company Roche. It was approved by the US FDA in May 2001. Valcyte is clinically used to treat acute retinitis caused by CMV infection in patients with acquired immunodeficiency syndrome. In May 2003, its indications were expanded. Valcyte is used to prevent and treat secondary CMV infection in organ transplant recipients. On August 11, 2010, Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) approved valganciclovir hydrochloride (Valcyte) for the treatment of adult kidney transplant patients at high risk for cytomegalovirus (CMV) disease.

How much does Valganciclovir Hydrochloride Tablets cost?

Roche's valganciclovir hydrochloride has been launched in China and is currently available in major infectious disease hospitals and pharmacies.

However, because it is an imported original drug, the price is relatively expensive. The domestic valganciclovir hydrochloride specification is 450mg-60 tablets/box, and the price is about RMB 16,500.

If patients feel that the price of valganciclovir hydrochloride in China is unaffordable, they can also choose valganciclovir hydrochloride, the original drug sold by Roche in India. The price is the lowest in the world, and it is also the one most purchased by domestic and foreign patients. Indian valganciclovir hydrochloride tablets, 450mg*60 tablets/box, sell for about RMB 5,500. Due to the floating exchange rate, the price is not fixed. Please consult Medical Travel for specific prices.

Warm reminder: Because valganciclovir is rapidly converted into ganciclovir in large quantities, studies on its reproductive toxicity have not been repeated. In animal experiments, ganciclovir caused reduced fertility and teratogenic effects. It is recommended that women of childbearing potential use effective contraceptive measures during treatment. Male patients are advised to use barrier contraception during tablet treatment and for at least 90 days after discontinuation of tablets.